RHO and retinal degeneration: Upon delivery to mice by intraperitoneal injection, PR3 has been found to be safe and effective in mitigating retinal degeneration, and improving visual function in the P23H rhodopsin mouse model (Nakamura et al., 2017), suggesting photoregulins are attractive preclinical candidates to treat humans with RHO-related adRP.